← Database
M&A

THE PRIVATE CLINIC (TPC)

Acquired by

QUADRIVIO GROUP

UNITED KINGDOM Health Providers REV [1m GBP - 100m GBP] 08/2023

Target

THE PRIVATE CLINIC (TPC)

Acquirer

QUADRIVIO GROUP

Context

Quadrivio Group has acquired a majority stake in The Private Clinic from BlueGem Capital Partners to serve as a platform for its "Silver Economy" strategy. The industrial logic is anchored in the "healthy longevity" megatrend: as the population ages, demand for aesthetic and wellness treatments among the affluent over-50s is booming. The transaction was structured as a simultaneous "Buy-and-Build" play, as TPC acquired four smaller clinics specializing in cosmetic medicine at closing to immediately scale its footprint. Quadrivio aims to use TPC to consolidate the highly fragmented aesthetic market in the UK and plans to export this business model to Italy and broader Europe, where similar consolidation opportunities exist.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded over 40 years ago and headquartered on London's Harley Street, The Private Clinic (TPC) is a premium provider of medical cosmetic treatments. It operates a network of seven clinics and one hospital (The Fitzroy Hospital) across the UK. The group offers a comprehensive range of procedures, ranging from plastic surgery and liposuction to non-invasive skin treatments, hair transplants, and varicose vein removal.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2023
LOGIN
LOGIN
LOGIN
2022
LOGIN
LOGIN
LOGIN

Other operations with THE PRIVATE CLINIC (TPC)

mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.